Theseus Pharmaceuticals, Inc. 8-K SEC Filings

Filed On	Filing
14 Feb 2024	8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more
22 Dec 2023	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +2 more
04 Dec 2023	8-K: Departure/Election of Directors or Officers; Compensation
27 Nov 2023	8-K: Other Events
13 Nov 2023	8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities +3 more
31 Oct 2023	8-K: Termination of a Material Definitive Agreement
10 Aug 2023	8-K: Results of Operations and Financial Condition
13 Jul 2023	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
09 Jun 2023	8-K: Submission of Matters to a Vote of Security Holders
25 May 2023	8-K: Regulation FD Disclosure; Other Events
11 May 2023	8-K: Results of Operations and Financial Condition
09 Mar 2023	8-K: Results of Operations and Financial Condition
05 Jan 2023	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
03 Nov 2022	8-K: Results of Operations and Financial Condition
19 Oct 2022	8-K: Departure/Election of Directors or Officers; Compensation
11 Aug 2022	8-K: Results of Operations and Financial Condition
13 Jun 2022	8-K: Submission of Matters to a Vote of Security Holders
18 May 2022	8-K: Departure/Election of Directors or Officers; Compensation
12 May 2022	8-K: Results of Operations and Financial Condition
10 Mar 2022	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Comments